A review of using Traditional Chinese Medicine in the management of glaucoma and cataract

Wong, Ka-Ying; Phan, Chau-Minh; Chan, Yat-Tin; Yuen, Ailsa Chui-Ying; Zhang, Huan; Zhao, Danyue; Chan, Ka-Yin; Do, Chi-Wai; Lam, Thomas Chuen; Qiao, Joanne Han; Wulff, David; Hui, Alex; Jones, Lyndon; Wong, Man-Sau

doi:10.1080/08164622.2023.2246480

Clinical and Experimental Optometry

2023

DOI: 10.1080/08164622.2023.2246480

|View full text |Cite

A review of using Traditional Chinese Medicine in the management of glaucoma and cataract

Ka-Ying Wong,

Chau-Minh Phan,

Yat-Tin Chan

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Nanozymes for Treating Ocular Diseases

Wong,

Liu

2024

Adv Healthcare Materials

View full text Add to dashboard Cite

Nanozymes, characterized by their nanoscale size and enzyme‐like catalytic activities, exhibit diverse therapeutic potentials, including anti‐oxidative, anti‐inflammatory, anti‐microbial, and anti‐angiogenic effects. These properties make them highly valuable in nanomedicine, particularly ocular therapy, bypassing the need for systemic delivery. Nanozymes show significant promise in tackling multi‐factored ocular diseases, particularly those influenced by oxidation and inflammation, like dry eye disease, and age‐related macular degeneration. Their small size, coupled with their ease of modification and integration into soft materials, facilitates the effective penetration of ocular barriers, thereby enabling targeted or prolonged therapy within the eye. This review is dedicated to exploring ocular diseases that are intricately linked to oxidation and inflammation, shedding light on the role of nanozymes in managing these conditions. Additionally, recent studies elucidating advanced applications of nanozymes in ocular therapeutics, along with their integration with soft materials for disease management, are discussed. Finally, this review outlines directions for future investigations aimed at bridging the gap between nanozyme research and clinical applications.This article is protected by copyright. All rights reserved

show abstract

Nanozymes for Treating Ocular Diseases

Wong,

Liu

2024

Adv Healthcare Materials

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A review of using Traditional Chinese Medicine in the management of glaucoma and cataract

Cited by 1 publication

References 73 publications

Nanozymes for Treating Ocular Diseases

Nanozymes for Treating Ocular Diseases

Contact Info

Product

Resources

About